Evidence map›Paper›PMID 40672479›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Associations of

Mahnaz Shekari, Armand González Escalante, Marta Milà-Alomà, Carles Falcon, David López-Martos, Gonzalo Sánchez-Benavides, Anna Brugulat-Serrat, Aida Niñerola-Baizán, Nicholas J Ashton, Thomas K Karikari and 23 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Armand González Escalante
Marta Milà-Alomà
Carles Falcon
David López-Martos
Gonzalo Sánchez-Benavides
Anna Brugulat-Serrat
Aida Niñerola-Baizán
Nicholas J Ashton
Thomas K Karikari
Juan Lantero-Rodriguez
Laia Montoliu-Gaya
Anniina Snellman
Theresa A Day
Jeffrey L Dage
Paula Ortiz-Romero
Matteo Tonietto
Edilio Borroni
Gregory Klein
Gwendlyn Kollmorgen
Margherita Carboni
Clara Quijano-Rubio
Eugeen Vanmechelen
Carolina Minguillón
Karine Fauria
Andrés Perissinotti
José Luis Molinuevo
Henrik Zetterberg
Kaj Blennow
Oriol Grau-Rivera
Marc Suárez-Calvet
Juan Domingo GispertORCID 0000-0002-6155-0642
ALFA Study

Funding

Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in bloodR01AG083874 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Thomas K Karikari · 2023 to 2026
$14.5M
NIA NIH HHS R01 AG083874
6 · The paper itself

Abstract

introductionWe investigated the presence of neurofibrillary tangles (NFT) and their association with amyloid plaques and fluid biomarkers of Alzheimer's disease (AD) in cognitively unimpaired individuals (CU).

methodsNinety-nine CU individuals from the ALFA+ cohort underwent tau PET using

resultsNine cases were Braak-I/II positive, five Braak-III/IV, and one Braak-V/VI. For CSF biomarkers, the strongest associations with Braak-I/II reached r=0.58 [95%CI:0.26-0.79, p<0.001, CSF ptau217] and, for plasma, r=0.25 [95%CI:0.03-0.45, p=0.01, plasma ptau181/Aβ42], but showed low PPVs [0.09-0.33] for Braak-I/II positivity. DISCUSSION:

Identifiers

PMID40672479
PMCPMC12265785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.